AIC
EW icon

Archer Investment Corporation’s Edwards Lifesciences EW Stock Holding History

Archer Investment Corporation’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Hold
138
– – ﹤0.01% 767
2026
Q1 		$11K Hold
138
– – ﹤0.01% 774
2025
Q4 		$11.7K Hold
138
– – ﹤0.01% 700
2025
Q3 		$10.7K Hold
138
– – ﹤0.01% 724
2025
Q2 		$10.8K Sell
138
-5
-3% -$373 ﹤0.01% 697
2025
Q1 		$10.3K Buy
143
+71
+99% +$5.08K ﹤0.01% 685
2024
Q4 		$5.31K Hold
72
– – ﹤0.01% 817
2024
Q3 		$4.74K Sell
72
-73
-50% -$5.3K ﹤0.01% 824
2024
Q2 		$13.4K Sell
145
-47
-24% -$4.16K ﹤0.01% 618
2024
Q1 		$18.3K Hold
192
– – 0.01% 552
2023
Q4 		$14.6K Hold
192
– – ﹤0.01% 589
2023
Q3 		$13.3K Hold
192
– – ﹤0.01% 575
2023
Q2 		$18.1K Buy
192
+98
+104% +$8.52K 0.01% 527
2023
Q1 		$7.78K Buy
+94
New +$7.39K ﹤0.01% 604

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Archer Investment Corporation's EW Position: Q2 2026 in Review

Archer Investment Corporation held its Edwards Lifesciences (EW) position steady in Q2 2026 at 138 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Archer Investment Corporation first reported a position in EW in Q1 2023 and has held it in 14 quarters since. The position peaked at $18.3K in Q1 2024. 979 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Archer Investment Corporation held 138 shares of Edwards Lifesciences worth $12.5K as of Q2 2026.
  • Archer Investment Corporation left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #767 holding.
  • Archer Investment Corporation first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 14 quarters since.
  • Archer Investment Corporation's Edwards Lifesciences position peaked at $18.3K in Q1 2024.
  • 979 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.